HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A study on transference of cefmenoxime into the cerebrospinal fluid].

Abstract
Two grams of cefmenoxime (CMX) was administered by one-shot intravenous injection to the patients in normal pressure hydrocephalus without meningitis, and the transference of CMX into the cerebrospinal fluid (CSF) from blood was investigated. After the injection of CMX, CSF and serum were serially taken, and the concentrations of CMX were measured by agar-well method using E. coli. The conclusions drawn from this study are summarized as follows: The concentrations of CMX in CSF were more slowly decreased than those in serum. The mean ratio of transference of CMX into CSF from the serum was 1.4%. After the intravenous injection of 2 g CMX, the mean maximum concentration of CMX in CSF was 0.36 microgram/ml, which exceeded 80% MIC (minimal inhibitory concentration) against several Gram-positive cocci and Gram-negative rods, and higher concentrations than the 80% MIC were kept over 4 hours in CSF. The efficacy of CMX may be kept by its injections less than 4 times a day.
AuthorsY Shibata, H Nogaki, K Ishida, T Kawaguchi
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 38 Issue 1 Pg. 45-8 (Jan 1985) ISSN: 0368-2781 [Print] Japan
PMID3857362 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cefmenoxime
  • Cefotaxime
Topics
  • Aged
  • Cefmenoxime
  • Cefotaxime (administration & dosage, analogs & derivatives, blood, cerebrospinal fluid)
  • Female
  • Humans
  • Hydrocephalus, Normal Pressure (blood, cerebrospinal fluid)
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Subarachnoid Hemorrhage (blood, cerebrospinal fluid)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: